What are the considerations for a 58-year-old patient with hypertension, diabetes, and coronary artery disease with stents undergoing an open left inguinal hernia repair with mesh?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Open Left Inguinal Hernia Repair with Mesh in High-Risk Cardiac Patient

For this 58-year-old patient with coronary artery disease and stents, proceed with open mesh repair using synthetic mesh with appropriate perioperative antiplatelet management, as mesh repair significantly reduces recurrence rates (50-75% reduction) compared to non-mesh techniques, and the cardiovascular comorbidities do not contraindicate mesh placement in clean surgical fields. 1

Perioperative Antiplatelet Management

This patient's coronary stents require careful antiplatelet drug management to balance thrombotic and bleeding risks:

  • Continue aspirin (75-100 mg daily) throughout the perioperative period without interruption, as this is a low-bleeding-risk procedure 2
  • If on dual antiplatelet therapy (DAPT) with clopidogrel: Continue both aspirin and clopidogrel if stents were placed within the past 12 months, as interruption increases stent thrombosis risk 2
  • If stents are >12 months old: Aspirin monotherapy is sufficient for this procedure 2
  • Avoid prasugrel or ticagrelor substitution—clopidogrel is the P2Y12 inhibitor of choice for patients requiring anticoagulation or at bleeding risk 2

The key pitfall is stopping antiplatelet therapy unnecessarily, which dramatically increases cardiac event risk in patients with recent stents.

Cardiovascular Risk Optimization

Blood Pressure Control

  • Target systolic BP 120-130 mmHg preoperatively (or 130-140 mmHg given age >65 years) 2
  • Continue beta-blockers and ACE inhibitors/ARBs through the morning of surgery, as these reduce perioperative cardiac events 2

Glycemic Control

  • Target HbA1c control to reduce surgical site infection risk, though specific targets are not defined for hernia surgery 2
  • Avoid hypoglycemia perioperatively, which increases cardiac risk 2

Statin Therapy

  • Continue statin therapy perioperatively without interruption 2

Surgical Technique Selection

Open mesh repair is the appropriate choice for this patient, offering several advantages:

  • Mesh repair reduces recurrence by 50-75% compared to non-mesh techniques (Peto OR: 0.37,95% CI: 0.26-0.51) 1
  • Operating time is comparable or slightly shorter than complex non-mesh repairs (7-10 minutes less than Shouldice) 1
  • Return to activities is faster with mesh repair 1
  • Chronic pain rates may be lower with mesh compared to non-mesh repair 1

Mesh Selection

  • Use synthetic polypropylene mesh in this clean surgical field (CDC Class I), as it provides optimal durability with low infection risk 3, 4
  • Large-pore synthetic mesh demonstrates superior infection resistance compared to small-pore designs 3
  • Mesh infection risk is only 1.9-5% even in higher-risk patients 3

Risk Factor Mitigation

This patient has multiple factors that increase complication risk:

Hypertension

  • Hypertension significantly increases acute postoperative complications (p=0.027) in inguinal hernioplasty 5
  • Ensure BP is optimally controlled preoperatively with target <130/80 mmHg 2

Diabetes

  • Diabetes increases wound complications and infection risk 5
  • Optimize glucose control preoperatively 2
  • Consider perioperative glucose monitoring 2

Coronary Artery Disease

  • This patient is at very high cardiovascular risk requiring aggressive risk factor management 2
  • Ensure cardiac medications (beta-blockers, ACE inhibitors, statins) are continued 2

Antibiotic Prophylaxis

Administer single-dose preoperative antibiotic prophylaxis (typically cefazolin 2g IV within 60 minutes of incision):

  • Prophylaxis is particularly important given this patient's risk factors: diabetes, hypertension, and cardiovascular disease 4
  • Emergency operations, ASA score ≥3, and longer operative duration increase mesh infection risk 3, 4
  • This patient likely has ASA score ≥3 given multiple comorbidities 3

Proton Pump Inhibitor Therapy

Prescribe routine PPI therapy perioperatively:

  • PPIs are recommended for patients on aspirin monotherapy or DAPT who are at high GI bleeding risk 2
  • This patient's age, antiplatelet therapy, and comorbidities constitute high GI bleeding risk 2

Anesthetic Considerations

Local or regional anesthesia is preferred over general anesthesia when feasible:

  • Reduces cardiac stress and allows faster recovery 6
  • Open inguinal hernia repair can be performed safely under local anesthesia 6
  • Discuss with anesthesia team given cardiac history 6

Expected Outcomes

With appropriate perioperative management:

  • Recurrence rate with mesh: 0.8-2% at short-term follow-up 6, 1
  • Mean operative time: approximately 40-45 minutes 6
  • Hospital stay: typically 1-2 days or same-day discharge if no complications 6, 1
  • Return to usual activities: faster than non-mesh repair 1

Critical Pitfalls to Avoid

  • Never discontinue aspirin perioperatively in patients with coronary stents—the thrombotic risk far exceeds bleeding risk for this procedure 2
  • Do not interrupt DAPT if stents are <12 months old without cardiology consultation 2
  • Ensure BP is controlled preoperatively—uncontrolled hypertension significantly increases complications 5
  • Do not omit antibiotic prophylaxis—this patient has multiple risk factors for infection 4
  • Avoid rapid ascites removal if present—not applicable here but important consideration in similar patients 3

References

Research

Open mesh versus non-mesh for repair of femoral and inguinal hernia.

The Cochrane database of systematic reviews, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mesh Repair for Umbilical Hernias

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Prophylaxis for Inguinal Hernia Repair with Mesh

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Open mesh-plug technique in inguinal hernia repair--short-term results.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.